湖北省生物医药产业链构建研究
|
摘要
完整的产业链是生物医药产业健康发展的必要条件。运用产业链来理解和阐释生物医药产业能够为区域生物医药产业目标政策的设计和实施提供比产业集群更广阔的思路和工具。湖北省虽然具有发展生物医药产业的良好基础条件,但是一直未转化成区域产业竞争中的比较优势。当前正是湖北发展生物医药产业的重要战略机遇期,能否采取恰当的思路推进产业发展关系到未来能否取得竞争优势。因此本文的研究目的就是通过构建生物医药产业链,加快湖北生物医药产业发展,提升产业整体竞争力。
根据产业组织和产业链的相关理论,文章首先对生物医药产业链本身的基本特征、要素组成、构建模式进行了深入的理论分析,提出了生物医药产业链的理论结构、构建的核心要素、基本模式及其演化规律。通过集中分析湖北省生物医药产业链现状,概括出该产业链在规模、结构、模式和布局方面的主要问题。通过SWOT分析法对构建湖北省生物医药产业链的内外部态势进行了综合分析,给出了湖北省生物医药产业链构建的产业细分、环节合理配置、产业集群和环境优化四种具体战略。依据构建的基本原则,在总结国内外生物医药产业链(群)建设方面的成功经验模式的基础上,提出了湖北应选择“以领导模式为主导,关系型和模块化模式为辅助的复合模式”。最后,文章从组织关系和空间布局两个层次初步设计了湖北生物产业链的理想结构,并给出了对策建议。
The complete industry chain is a necessary condition for the healthy development of the bio-pharmaceutical industry. Using the industrial chain to understand and explain the biomedical industry can provide government with the idea that is broader and more useful than industrial clusters in designing regional policy and choosing implementation tools. Although Hubei Province has good basic conditions for the development of the bio-pharmaceutical industry,they have not been transformed into a regional comparative advantage in industrial competition. At present,there is an important strategic opportunity for Hubei to develop the bio-pharmaceutical industry.If we can not take the appropriate idea to promote the development of the bio-pharmaceutical industry,Hubei probably loses the chance of getting competitive advantage again. Therefore,the purpose of this study is to construct bio-pharmaceutical industry which could enhance the overall competitiveness of the industry in Hubei.
According to industrial organization and the theory of industrial chain, this paper firstly made a thorough analysis on the basic characteristics, elements, model in-depth, and put forward the theoretical structure, the elements of construction, the basic models. The article analyzed the current situation of the biomedical industry chain in Hubei Province, and summarized the main problems, including the size, structure, pattern and layout of the industry chain. Then, The paper used the method of SWOT to analysis on the external situation of constructing the biomedical industry chain in Hubei. In the following, the article presents a multi strategy, including the industry segments, reasonable configuration, optimization of industrial clusters and improving the environment. Based on the principles of constructing the biomedical industry chain, and referred to the domestic and international bio-pharmaceutical industry chain (s) the successful construction experiences,the paper proposes Hubei should select the the complex model of leadership-oriented,relational and modular model for the secondary model. Finally,the article preliminarily designs the ideal structure of the industry chain from the organizational relationships and spatial distribution,and gives policy-support suggestions.
根据产业组织和产业链的相关理论,文章首先对生物医药产业链本身的基本特征、要素组成、构建模式进行了深入的理论分析,提出了生物医药产业链的理论结构、构建的核心要素、基本模式及其演化规律。通过集中分析湖北省生物医药产业链现状,概括出该产业链在规模、结构、模式和布局方面的主要问题。通过SWOT分析法对构建湖北省生物医药产业链的内外部态势进行了综合分析,给出了湖北省生物医药产业链构建的产业细分、环节合理配置、产业集群和环境优化四种具体战略。依据构建的基本原则,在总结国内外生物医药产业链(群)建设方面的成功经验模式的基础上,提出了湖北应选择“以领导模式为主导,关系型和模块化模式为辅助的复合模式”。最后,文章从组织关系和空间布局两个层次初步设计了湖北生物产业链的理想结构,并给出了对策建议。
The complete industry chain is a necessary condition for the healthy development of the bio-pharmaceutical industry. Using the industrial chain to understand and explain the biomedical industry can provide government with the idea that is broader and more useful than industrial clusters in designing regional policy and choosing implementation tools. Although Hubei Province has good basic conditions for the development of the bio-pharmaceutical industry,they have not been transformed into a regional comparative advantage in industrial competition. At present,there is an important strategic opportunity for Hubei to develop the bio-pharmaceutical industry.If we can not take the appropriate idea to promote the development of the bio-pharmaceutical industry,Hubei probably loses the chance of getting competitive advantage again. Therefore,the purpose of this study is to construct bio-pharmaceutical industry which could enhance the overall competitiveness of the industry in Hubei.
According to industrial organization and the theory of industrial chain, this paper firstly made a thorough analysis on the basic characteristics, elements, model in-depth, and put forward the theoretical structure, the elements of construction, the basic models. The article analyzed the current situation of the biomedical industry chain in Hubei Province, and summarized the main problems, including the size, structure, pattern and layout of the industry chain. Then, The paper used the method of SWOT to analysis on the external situation of constructing the biomedical industry chain in Hubei. In the following, the article presents a multi strategy, including the industry segments, reasonable configuration, optimization of industrial clusters and improving the environment. Based on the principles of constructing the biomedical industry chain, and referred to the domestic and international bio-pharmaceutical industry chain (s) the successful construction experiences,the paper proposes Hubei should select the the complex model of leadership-oriented,relational and modular model for the secondary model. Finally,the article preliminarily designs the ideal structure of the industry chain from the organizational relationships and spatial distribution,and gives policy-support suggestions.
引文
[1]冉庆国.产业集群与产业链的关系研究[J].Study& Exploration,2009(3): 160-162
[2]陈朝隆.区域产业链构建研究[D]:中山大学.2007:5
[3]李连芬.西部地区生物医药产业集群化发展研究[D]:西北大学.2007:16-18
[4]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:37-38
[5]邓永丽.生物医药研发服务业的特征与发展规律研究[D]:中国人民解放军军事医学科学院.2007:37-38
[6]张泽工,李琼等.北京市生物工程和新医药产业链研究报告:2003
[7]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:46-50
[8]郑海涛.生物医药产业的创新链模式研究[J].科技进步与对策.2003:113-114
[9]吴曙霞,李培进,蔡国友等.基于区域竞争力的生物医药产业规划研究[J].科技情报开发与经济.2005 (21):129
[10]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:124
[11]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009:35
[12]龚勤林.区域产业链研究[D]:四川大学.2004:44-48
[13]刘艳辉,尹贻林.基于产业链视角的高科技产业化发展研究.现代管理科学, 2009(5):68-70
[14]史静.我国生物医药行业的战略联盟研究——契约式战略联盟下选择战略伙伴的定位标准[D].北京化工大学.2004:27
[15]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009:44-46
[16]北京将兴建亚洲最大的全球生物制药合同生产基地. http://www.gov.cn/jrzg/2010-03/09/content_1551589.htm.
[17]徐磊.我国生物医药产业发展的前瞻性研究[J].中国医药技术经济与管理,2008(9):15
[18]中医药国际化迈出坚实一步.http://www.yyjjb.com.cn/html/2010-09/17/content_121636.htm.
[19]关于加快发展我省生物医药产业的调研报告. http://www.hbzyw.gov.cn/xwxx.asp?id=9066.
[20]王冬梅.湖北省生物医药产业集群培育策略研究[J].科技进步与对策. 2009, 26(12):47-49
[21]湖北生物医药产业已形成六大优势产品. http://www.most.gov.cn/dfkjgznew/200801/t20080108_58267.htm.
[22]湖北省关于转发省发展改革委湖北省生物产业发展规划(2008—2015年)的通知.湖北省人民政府公报:2008(15):32-38
[23]陈朝隆.区域产业链构建研究[D]:中山大学.2007:150
[1] Frank T.Rothaermel.Complementary assets ,strategic alliances,and the incumbent’s advantage:an empirical study of industry and firm effects in the biopharmaceutical industry[J],Research Policy,2001(30):1235–1251
[2] Stefan Wuyts , Shantanu Dutta . Licensing exchange—Insights from the biopharmaceutical industry[J],Intern.J.of Research in Marketing,2008(25):273–281
[3] Zeynep Erden.Strategic groups in the biopharmaceutical industry:implications for performance[J],PERSPECTIVE,2009(14):726-730
[4] Jing Zhang,Charles Baden-Fuller,Vincent Mangematin.Technological knowledge base,R&D organization structure and alliance formation:Evidence from the biopharmaceutical industry[J],Research Policy 2007(36) :515–528
[5] Vito Albino,Nunzia Carbonara,Ilaria Giannoccaro.Supply chain cooperation in industrial districts:A simulation analysis[J],European Journal of Operational Research,2007(177):261–280
[6] C.W.Holsapple,M.Singh.The knowledge chain model:activities for competitiveness[J],Expert Systems with Applications,2001(20):77-98
[7] M.Kannegiesser,H.O.Günther,P.van Beek,M.Grunow,C.Habla.Value chain management for commodities:a case study from the chemical industry[J] ,OR Spectrum,2009(31):63–93
[8] Dermot Fennelly,Kathryn Cormican.Value chain migration from production to product centred operations:an analysis of the Irish medical device industry[J],Technovation,2006(26):86–94
[9] Andreas Hinterhuber.Value Chain Orchestration in Action and the Case of theGlobal Agrochemical Industry[J],Long Range Planning,2002(35):615–635
[10] Wang HG..Development Biotechnology Leading Bioecnonmy.Beijing:China[J], Medical Scientific and Technical Publishers,2005:334
[11] Michael E.Porter.The competitive advantage of ations:.Li MX,QiuRM,trans.Beijing:Huaxia Publishing House,2002:40
[12] Zheng SL.Analysis on the global extension of industry chains and theregional industrial development in China[J],Mod Econ Sci,2005(1):87-93
[13] Li ZJ.Quicken the biotechnology industry development step,cultivate the new economy increase point[J],China Biotechnol,2004(10):85-88
[14] Department of High-Tech Industry of the Nationgal Development andReform Commission,Chinese Society of Biotechnolory.Annualreport on bioindustry in China:2005.Beijing:Chemical IndustryPress,2006:9
[15] Zheng HT.An innovative chain model for the development ofbio-pharmaceutics industry.Sci Technol Prog Policy,2003(7):113-115
[16] Acs Z J,Anselin Luc,Varga Attila.Patents and Innovation Countsas Measures of Regional Production of New Knowledge [J].Research Policy,2002(31):1069 -1085
[17] GroshbyMark.Patents:Innovation and Growth[J].Economic Record,2000(76) :255-262
[18] Jaffe Adam B.The US.Patent System in Transition:Policy Innovation and the Innovation Process [J].Research Policy,2000(29):531 - 557
[19]蔡宇.关于产业链理论架构与核心问题的思考[J].财经论坛.2006(9):114-116
[20]陈朝隆.区域产业链构建研究[D]:中山大学.2007
[21]龚勤林.区域产业链研究[D]:四川大学.2004
[22]胡国平.产业链稳定机制研究[D]:西南财经大学.2006
[23]贺蕾.全球生物医药产业价值链的动态变化及其政策含义[J].湖南社会科学.2007(6):209-212
[24]黄正平.产业链促进经济增长的作用机理研究[J],理论研讨.2009(35):81-82
[25]季云涛.基于_三链一力_的产业选择和升级研究[D]:复旦大学.2006
[26]蒋国俊.产业链理论及其稳定机制研究[J].重庆大学学报(社会科学版),2003(1):36-38
[27]李心芹,李仕明,兰永.产业链结构类型研究[J].电子科技大学学报社科版,2004(4):61-63
[28]李心芹.产业链若干问题研究_特性_类型_利益分配[D]:电子科技大学.2005
[29]李静潭.中国生物医药产业发展模式研究[D]:北京化工大学.2006
[30]刘尔思.关于产业链理论的再探索[J].云南财经大学学报,2006(3):66-69
[31]刘贵富.产业链基本理论研究[D]:吉林大学.2006
[32]刘贵富,赵英才.产业链节点企业研究[J].工业技术经济,2006(9):61-64
[33]刘慧波.产业链纵向整合研究[D].浙江大学.2009
[34]刘志迎,赵倩.产业链概念_分类及形成机理研究述评[J].工业技术经济,2009(10):51-55
[35]刘艳辉,尹贻林.基于产业链视角的高科技产业化发展研究.现代管理科学,2009(5):68-70.
[36]乔建勇.产业链对区域经济增长影响的研究[D]:中南大学.2006
[37]王云霞,李国平.产业链现状研究综述[J].工业技术经济,2006(10):59-63
[38]王苑.现代服务业产业链的理论与实证研究[D]:武汉理工大学.2008
[39]王冬梅.湖北省生物医药产业集群培育策略研究[J].科技进步与对策,2009(12):47-49
[40]王冬梅,张金隆.湖北省医药产业发展的现状及对策分析[J].科技进步与对策,2008(12):62-65
[41]王兴元,高新技术产业链结构类型_功能及其培育策略[J].科学学与科学技术管理,2005(3):88-93
[42]吴金明,张磐,赵曾琪.产业链_产业配套半径与企业自生能力[J].中国工业经济,2005(2):44-50
[43]吴金明,钟键能,黄进良.龙头企业_产业七寸_与产业链培育[J].中国工业经济,2007(1):53-60
[44]吴曙霞,李培进,蔡国友等.基于区域竞争力的生物医药产业规划研究[J].科技情报开发与经济,2005(21):129-130
[45]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009
[46]张雷.产业链纵向关系治理模式研究[D]:复旦大学.2007
[47]吴晓隽,高汝熹,杨舟.美国生物医药产业集群的模式特点及启示[J].中国科技论坛.2008(1):132-135
[48]肖勤.上海浦东生物医药产业集群研究[D]:华东师范大学.2006
[49]辛群涛.山东省生物_医药高新技术产业链培育规划[D]:山东大学.2005
[50]邢来田,黄涛,候锦如等.生物医药科技与产业发展对策研究[J].中国软科学,2003(3):100-103
[51]徐磊.我国生物医药产业发展的前瞻性研究[J].中国医药技术经济与管理,2008(9):14-19
[52]闫希军.现代中药产业链管理系统研究[D]:南京农业大学.2007
[53]杨莲芬.杭州市生物医药产业的SWOT分析及发展研究[J].商场现代化,2008(12):265-267
[54]张铁男,罗晓梅.产业链分析及其战略环节的确定研究[J].中国工业经济,2005(6):77-78
[55]周新生.产业链与产业链打造[J].广东社会科学.2006(4):30-36
[56]张可菡,茅蕾.政府_市场和企业在美国生物医药产业发展中的作用[J].商场现代化,2008(3):242-243
[57]郑海涛.生物医药产业的创新链模式研究[J].科技进步与对策.2003:113-115
[58]周德胜.生物制药产业化影响因素及作用机理研究[D].大连理工大学.2008
[59]湖北省关于转发省发展改革委湖北省生物产业发展规划(2008—2015年)的通知.湖北省人民政府公报:2008(15):32-38
[2]陈朝隆.区域产业链构建研究[D]:中山大学.2007:5
[3]李连芬.西部地区生物医药产业集群化发展研究[D]:西北大学.2007:16-18
[4]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:37-38
[5]邓永丽.生物医药研发服务业的特征与发展规律研究[D]:中国人民解放军军事医学科学院.2007:37-38
[6]张泽工,李琼等.北京市生物工程和新医药产业链研究报告:2003
[7]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:46-50
[8]郑海涛.生物医药产业的创新链模式研究[J].科技进步与对策.2003:113-114
[9]吴曙霞,李培进,蔡国友等.基于区域竞争力的生物医药产业规划研究[J].科技情报开发与经济.2005 (21):129
[10]马彦.生物医药产业价值链的整合化研究[D]:复旦大学.2009:124
[11]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009:35
[12]龚勤林.区域产业链研究[D]:四川大学.2004:44-48
[13]刘艳辉,尹贻林.基于产业链视角的高科技产业化发展研究.现代管理科学, 2009(5):68-70
[14]史静.我国生物医药行业的战略联盟研究——契约式战略联盟下选择战略伙伴的定位标准[D].北京化工大学.2004:27
[15]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009:44-46
[16]北京将兴建亚洲最大的全球生物制药合同生产基地. http://www.gov.cn/jrzg/2010-03/09/content_1551589.htm.
[17]徐磊.我国生物医药产业发展的前瞻性研究[J].中国医药技术经济与管理,2008(9):15
[18]中医药国际化迈出坚实一步.http://www.yyjjb.com.cn/html/2010-09/17/content_121636.htm.
[19]关于加快发展我省生物医药产业的调研报告. http://www.hbzyw.gov.cn/xwxx.asp?id=9066.
[20]王冬梅.湖北省生物医药产业集群培育策略研究[J].科技进步与对策. 2009, 26(12):47-49
[21]湖北生物医药产业已形成六大优势产品. http://www.most.gov.cn/dfkjgznew/200801/t20080108_58267.htm.
[22]湖北省关于转发省发展改革委湖北省生物产业发展规划(2008—2015年)的通知.湖北省人民政府公报:2008(15):32-38
[23]陈朝隆.区域产业链构建研究[D]:中山大学.2007:150
[1] Frank T.Rothaermel.Complementary assets ,strategic alliances,and the incumbent’s advantage:an empirical study of industry and firm effects in the biopharmaceutical industry[J],Research Policy,2001(30):1235–1251
[2] Stefan Wuyts , Shantanu Dutta . Licensing exchange—Insights from the biopharmaceutical industry[J],Intern.J.of Research in Marketing,2008(25):273–281
[3] Zeynep Erden.Strategic groups in the biopharmaceutical industry:implications for performance[J],PERSPECTIVE,2009(14):726-730
[4] Jing Zhang,Charles Baden-Fuller,Vincent Mangematin.Technological knowledge base,R&D organization structure and alliance formation:Evidence from the biopharmaceutical industry[J],Research Policy 2007(36) :515–528
[5] Vito Albino,Nunzia Carbonara,Ilaria Giannoccaro.Supply chain cooperation in industrial districts:A simulation analysis[J],European Journal of Operational Research,2007(177):261–280
[6] C.W.Holsapple,M.Singh.The knowledge chain model:activities for competitiveness[J],Expert Systems with Applications,2001(20):77-98
[7] M.Kannegiesser,H.O.Günther,P.van Beek,M.Grunow,C.Habla.Value chain management for commodities:a case study from the chemical industry[J] ,OR Spectrum,2009(31):63–93
[8] Dermot Fennelly,Kathryn Cormican.Value chain migration from production to product centred operations:an analysis of the Irish medical device industry[J],Technovation,2006(26):86–94
[9] Andreas Hinterhuber.Value Chain Orchestration in Action and the Case of theGlobal Agrochemical Industry[J],Long Range Planning,2002(35):615–635
[10] Wang HG..Development Biotechnology Leading Bioecnonmy.Beijing:China[J], Medical Scientific and Technical Publishers,2005:334
[11] Michael E.Porter.The competitive advantage of ations:.Li MX,QiuRM,trans.Beijing:Huaxia Publishing House,2002:40
[12] Zheng SL.Analysis on the global extension of industry chains and theregional industrial development in China[J],Mod Econ Sci,2005(1):87-93
[13] Li ZJ.Quicken the biotechnology industry development step,cultivate the new economy increase point[J],China Biotechnol,2004(10):85-88
[14] Department of High-Tech Industry of the Nationgal Development andReform Commission,Chinese Society of Biotechnolory.Annualreport on bioindustry in China:2005.Beijing:Chemical IndustryPress,2006:9
[15] Zheng HT.An innovative chain model for the development ofbio-pharmaceutics industry.Sci Technol Prog Policy,2003(7):113-115
[16] Acs Z J,Anselin Luc,Varga Attila.Patents and Innovation Countsas Measures of Regional Production of New Knowledge [J].Research Policy,2002(31):1069 -1085
[17] GroshbyMark.Patents:Innovation and Growth[J].Economic Record,2000(76) :255-262
[18] Jaffe Adam B.The US.Patent System in Transition:Policy Innovation and the Innovation Process [J].Research Policy,2000(29):531 - 557
[19]蔡宇.关于产业链理论架构与核心问题的思考[J].财经论坛.2006(9):114-116
[20]陈朝隆.区域产业链构建研究[D]:中山大学.2007
[21]龚勤林.区域产业链研究[D]:四川大学.2004
[22]胡国平.产业链稳定机制研究[D]:西南财经大学.2006
[23]贺蕾.全球生物医药产业价值链的动态变化及其政策含义[J].湖南社会科学.2007(6):209-212
[24]黄正平.产业链促进经济增长的作用机理研究[J],理论研讨.2009(35):81-82
[25]季云涛.基于_三链一力_的产业选择和升级研究[D]:复旦大学.2006
[26]蒋国俊.产业链理论及其稳定机制研究[J].重庆大学学报(社会科学版),2003(1):36-38
[27]李心芹,李仕明,兰永.产业链结构类型研究[J].电子科技大学学报社科版,2004(4):61-63
[28]李心芹.产业链若干问题研究_特性_类型_利益分配[D]:电子科技大学.2005
[29]李静潭.中国生物医药产业发展模式研究[D]:北京化工大学.2006
[30]刘尔思.关于产业链理论的再探索[J].云南财经大学学报,2006(3):66-69
[31]刘贵富.产业链基本理论研究[D]:吉林大学.2006
[32]刘贵富,赵英才.产业链节点企业研究[J].工业技术经济,2006(9):61-64
[33]刘慧波.产业链纵向整合研究[D].浙江大学.2009
[34]刘志迎,赵倩.产业链概念_分类及形成机理研究述评[J].工业技术经济,2009(10):51-55
[35]刘艳辉,尹贻林.基于产业链视角的高科技产业化发展研究.现代管理科学,2009(5):68-70.
[36]乔建勇.产业链对区域经济增长影响的研究[D]:中南大学.2006
[37]王云霞,李国平.产业链现状研究综述[J].工业技术经济,2006(10):59-63
[38]王苑.现代服务业产业链的理论与实证研究[D]:武汉理工大学.2008
[39]王冬梅.湖北省生物医药产业集群培育策略研究[J].科技进步与对策,2009(12):47-49
[40]王冬梅,张金隆.湖北省医药产业发展的现状及对策分析[J].科技进步与对策,2008(12):62-65
[41]王兴元,高新技术产业链结构类型_功能及其培育策略[J].科学学与科学技术管理,2005(3):88-93
[42]吴金明,张磐,赵曾琪.产业链_产业配套半径与企业自生能力[J].中国工业经济,2005(2):44-50
[43]吴金明,钟键能,黄进良.龙头企业_产业七寸_与产业链培育[J].中国工业经济,2007(1):53-60
[44]吴曙霞,李培进,蔡国友等.基于区域竞争力的生物医药产业规划研究[J].科技情报开发与经济,2005(21):129-130
[45]吴彦艳.产业链的构建整合及升级研究[D]:天津大学.2009
[46]张雷.产业链纵向关系治理模式研究[D]:复旦大学.2007
[47]吴晓隽,高汝熹,杨舟.美国生物医药产业集群的模式特点及启示[J].中国科技论坛.2008(1):132-135
[48]肖勤.上海浦东生物医药产业集群研究[D]:华东师范大学.2006
[49]辛群涛.山东省生物_医药高新技术产业链培育规划[D]:山东大学.2005
[50]邢来田,黄涛,候锦如等.生物医药科技与产业发展对策研究[J].中国软科学,2003(3):100-103
[51]徐磊.我国生物医药产业发展的前瞻性研究[J].中国医药技术经济与管理,2008(9):14-19
[52]闫希军.现代中药产业链管理系统研究[D]:南京农业大学.2007
[53]杨莲芬.杭州市生物医药产业的SWOT分析及发展研究[J].商场现代化,2008(12):265-267
[54]张铁男,罗晓梅.产业链分析及其战略环节的确定研究[J].中国工业经济,2005(6):77-78
[55]周新生.产业链与产业链打造[J].广东社会科学.2006(4):30-36
[56]张可菡,茅蕾.政府_市场和企业在美国生物医药产业发展中的作用[J].商场现代化,2008(3):242-243
[57]郑海涛.生物医药产业的创新链模式研究[J].科技进步与对策.2003:113-115
[58]周德胜.生物制药产业化影响因素及作用机理研究[D].大连理工大学.2008
[59]湖北省关于转发省发展改革委湖北省生物产业发展规划(2008—2015年)的通知.湖北省人民政府公报:2008(15):32-38